Overview Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers Status: Completed Trial end date: 2012-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether SYL1001 is safe for the prevention and treatment of ocular pain and dry eye syndrome. Phase: Phase 1 Details Lead Sponsor: Sylentis, S.A.